Al Hammadi Holding announces its Interim Financial Results for the Period Ending on 2023-06-30 ( Six Months )

Element ListCurrent QuarterSimilar Quarter For Previous Year%ChangePrevious Quarter% Change
Sales/Revenue276.66281.94-1.87298.6-7.35
Gross Profit (Loss)92.08109.09-15.59120.4-23.52
Operational Profit (Loss)93.1973.8826.1491.761.56
Net Profit (Loss) after Zakat and Tax81.8565.125.7381.420.53
Total Comprehensive Income81.1163.0428.6681.52-0.5
All figures are in (Millions) Saudi Arabia, Riyals
Element ListCurrent PeriodSimilar Period For Previous Year%Change
Sales/Revenue575.26532.837.96
Gross Profit (Loss)212.49205.173.57
Operational Profit (Loss)184.95143.9728.46
Net Profit (Loss) after Zakat and Tax163.27127.0628.5
Total Comprehensive Income162.63126.4828.58
Total Share Holders Equity (after Deducting Minority Equity)1,761.191,689.774.23
Profit (Loss) per Share1.020.79
All figures are in (Millions) Saudi Arabia, Riyals
Element ListExplanation
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year isNet profit during Q2 2023 recorded SAR 81.85 million, increasing 25.73% year-on-year from the SAR 65.1 million booked during the same quarter of the previous year. Net profit growth was mainly driven by the following:• Expected credit loss provision, which booked a credit loss reversal of SAR 17.84 million during the second quarter of 2023 as the Company continued improving collection rates.
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year isNet profit during Q2 2023 recorded SAR 81.85 million, up a marginal 0.53% q-o-q from SAR 81.42 million in Q1 2023. The increase in net profit during the quarter is mainly attributable to:• Expected credit loss provision, due to the Company recording a credit loss reversal of SAR 17.84 million during Q2 2023 compared to an expected credit loss of SAR 5.88 million in the previous quarter. The effects of the credit loss reversal, however, were mostly counteracted by lower revenues and gross profitability as a result of lower patient volumes due to the holy month of Ramadan and Eid vacations falling in the second quarter of the year.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year isNet profit reached SAR 163.27 million during 1H 2023, increasing 28.58% y-o-y from SAR 127.06 million in 1H 2022. The increase in net profit during the period was mainly driven by the following:• Revenues, which grew by 7.96% y-o-y to SAR 575.26 million during 1H 2023. Increased revenues for the period were dual driven by higher revenues reported by both Al Hammadi’s medical services and pharmaceutical segments.• Expected credit loss provision, which booked a credit loss reversal of SAR 17.84 million during the second quarter of 2023 bringing the net provision for expected credit losses reversed for the current period to SAR 11.96 million, compared to an expected credit loss of SAR 24.31 million in the same period of the previous year.
Statement of the type of external auditor’s reportUnmodified conclusion
Reclassification of Comparison ItemsNone

Pharmaceutical Services

Pharmaceutical Services Company, a subsidiary of Al Hammadi Holding, is a leading provider of essential medications, vaccinations, and drug distribution services. As a key component of Al Hammadi’s comprehensive health care offering, the Pharmaceutical Services Company plays a vital role in ensuring that patients have access to the necessary treatments to support their health and well-being.

Continuing Medical Education (CME)

The Continuing Medical Education (CME) was established in 1985 to meet the education and training needs of all hospital staff, whether medical personnel, doctors or non-medical staff nurses, assistants or technicians.

Training Institutes Women

The Support Services Institutes for Training opened branches for (women) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Training Institutes Men

The Support Services Institutes for Training opened branches for(Men) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Sudair Pharmaceutical

Sudair Pharmaceutical Company (SPC) is a leading Saudi-based pharmaceutical firm specializing in specialty care medications. Established in 2014, SPC aims to address unmet medical needs in Saudi Arabia and the MENA region, with a focus on cancer-fighting medications and other high-tech treatments for chronic and life-threatening diseases. Al Hammadi Holding Company owns 35% of SPC’s shares, bolstering its commitment to improve healthcare provision and secure the supply of advanced pharmaceuticals. SPC’s innovative business model, international partnerships, and dedication to integrity, quality, innovation, and community service make it an integral player in achieving KSA’s 2030 vision for better health outcomes.

Biopharma Industrial Park

The Biopharma Industrial Park is a progressive subsidiary of Al Hammadi Holding, operating at the forefront of biotechnology and life sciences innovation. As a pivotal contributor to Al Hammadi’s comprehensive health care services, the Biopharma Industrial Park is committed to driving advancements in medical research, development, and production. Its focus on cutting-edge technologies and scientific expertise enables the organization to make significant strides in improving patient care, as well as advancing the medical sector within the Kingdom of Saudi Arabia and beyond.

Construction & Maintenance

The Construction and Maintenance Company is a subsidiary of Al Hammadi Holding, specializing in providing high-quality hospital maintenance, engineering works, and other related services. As an integral part of the Al Hammadi group, this company plays a crucial role in ensuring the smooth and efficient functioning of health care facilities while maintaining a safe and comfortable environment for patients and medical staff, the company recently obtained certificates in quality, safety and environmental management.

Home Medical Care

Home Medical Care, a subsidiary of Al Hammadi Holding, provides comprehensive and personalized healthcare services to patients in the comfort of their own homes. This innovative approach to healthcare delivery aims to enhance patient satisfaction, reduce hospital readmissions, and improve overall patient outcomes. By offering a wide range of medical services in a familiar and comfortable environment, Home Medical Care strives to promote patient well-being and independence.

Telemedicine

Telemedicine Company, a subsidiary of Al Hammadi Holding, is at the forefront of revolutionizing healthcare delivery by leveraging advanced technology to provide remote medical services. This innovative approach to healthcare enables patients to access quality medical care from the comfort of their homes or workplaces, eliminating geographical barriers and reducing the burden on traditional healthcare facilities.

Unified Procurement

Unified Procurement, a subsidiary of Al Hammadi Holding, is a specialized company responsible for managing all medical and non-medical hospital purchases and supplies. As an integral part of Al Hammadi’s comprehensive health care services, Unified Procurement plays a vital role in ensuring that hospitals and clinics have access to the necessary equipment, supplies, and consumables needed to provide high-quality care to their patients.

Arabian Hospitality

Arabian Hospitality, a subsidiary of Al Hammadi Holding, is a prominent player in the domain of hospital support services, dedicated to maintaining the highest standards of hygiene, laundry, medical staff attire, and food services for patients. As an integral part of the Al Hammadi Holding group, Arabian Hospitality ensures a seamless and comfortable experience for both patients and medical staff, contributing to the overall excellence of the group’s health care offerings, the company recently obtained the certificates of Quality Management, Food Safety, Hazard Analysis and Critical Control Points.

Al Hammadi Hospital Al Narjis

Al Narjis Hospital – Expected launch in 2028 .Building on this, Al Hammadi is expecting to launch its fourth hospital in 2028. The facility will have a capacity of 200 rooms and 120 clinics and will house two centers of excellence focused on rehabilitation and plastic surgery. The facility will be located in Al Narjis neighborhood in the north of the Kingdom’s capital.

Al Hammadi Hospital Al Olaya

Al Olaya Hospital – Expected Launch in 2026 .Al Olaya Hospital was Al Hammadi’s first facility, originally launched back in 1985. At its peak, the facility was home to 200 inpatient rooms and 74 outpatient clinics. The facility was temporarily shut down in the final months of 2021 as management kicked off an extensive renovation plan aimed at constructing a new facility with a new infrastructure and a broader service offering. The revamped facility, which is planned to reopen in 2026, will have a capacity of 200 rooms and 120 clinics and will operate two centers of excellence focused on sports medicine and oncology. The facility is located in the Al Olaya neighborhood of Riyadh, which has historically been a business, commerce, and leisure hub in the city, rendering it a natural residential destination for expats and a large number of Saudi citizens.

Al Hammadi Hospital Al Suwaidi

Launched in 2015, Al Suwaidi Hospital is located in a strategic southwest neighborhood of KSA’s capital. Today, the facility houses 300 inpatient rooms, 80 outpatient clinics, and 13 operating rooms. The facility also has a cardiac catheterization room, two upper and lower endoscopy rooms, a kidney stone treatment room, and a lithotripsy room. The facility is equipped with the highest quality machinery and medical technology in the market, and services are provided by highly trained and experienced medical professionals. As of year-end 2022, 160 rooms were operational at the facility, with the remaining unutilized rooms offering easy-to-ramp-up capacity to match growing demand. The facility caters to both a significant pool of patients associated with the MOH and private insurance patients primarily from the medium and medium-upper class segment.

Al Hammadi Hospital Al Nuzha

Located in a northeast neighborhood of Riyadh and officially inaugurated in 2018, Al Nuzha Hospital was originally launched to cater predominately to medium and upper-medium class patients, leveraging its 300-room capacity, 100 outpatient clinics, and 13 operating rooms. In 2022, the facility continued its premiumization, converting double rooms into single rooms to cater to increasing demand from higher-income class A/VIP patients and enabling the Group to capitalize on the important growth opportunities offered by this expanding segment. Today, Al Nuzha Hospital offers a comprehensive range of medical services, all provided by the facility’s highly experienced medical staff